🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Proud of Daniel & the Shift team. He pivoted to novel cell rejuvenation tx that optimized for rejuvenation w/o de-differentiation before Altos, NewLimit, & Jacob Kimmel's Calico talks on it. One of the most important sub-areas of the aging field. This round is great validation

I’m glad to finally make public what I built over the last several months! CpG Pretrained Transformer (CpGPT) is a foundation model that is an outstanding tool for everything DNA methylation🧬. It achieves SOTA or near SOTA performance in virtually all the tasks I’ve tested so

Thanks to the AWS Health Innovation Podcast for hosting me. I talk about how Shift Bioscience we've used aging clocks inside cell simulations to find safer ways to make real human cells younger 🕚🕙🕗healthpodcastnetwork.com/episodes/aws-h…

Thrilled to share our new publication, “Histone mark age of human tissues and cell types,” in Science Advances! TL;DR 🔑 Accuracy: Histone mark ChIP-Seq data can be leveraged to build highly robust age predictors (r > 0.9). 🐕 Interpretation: Top genes are evolutionarily

To all the longevity biohackers and investors focused on lifestyle, apps, drug re-purposing and other "low hanging fruit. You're underestimating the scale of the problem, and you're not contributing meaningfully to the solution.

1/ 🚀 Excited to announce the release of our LongBio Report 2025 —comprehensively profiling the leading companies in longevity biotechnology. This is your guide to understanding the future of healthy lifespan extension. 👉Read the report:  healthspancapital.vc/longbio-report…

I’m excited to share that Shift Bioscience is expanding to North America to increase its capabilities in AI-powered virtual cells and their use for discovery of rejuvenation genes. Shift's Head of Machine Learning, Lucas Camillo @ollimacsacul, will be relocating to Toronto,

Shift Bio is leading the way in using foundation models for rejuvenation research! Excited to see the breakthroughs they’ll bring in the years ahead!

I’m excited to welcome Dr Jill Reckless and Dr Laurence Reid Laurence Reid to the Shift Bioscience team as Translation Advisor and Non-Executive Director respectively, to help advance our pipeline of rejuvenation therapeutics! Aging mechanisms are common to the majority of

1/ We're thrilled to announce Shift Bioscience Shift Bioscience as a sponsor of Vitalist Bay - our 8-week longevity zone dedicated to combating aging at the cellular level using groundbreaking AI technology. 🔬🧬💻

I’m excited to be part of a #SynBioBeta2025 panel discussing breakthroughs in epigenetic reprogramming and how this could transform Longevity biotech. Let’s connect in San Jose — whether you're building the next big thing in Longevity biotech, investing in the future, or just

I'll be speaking at Founders Longevity Forum in London on 10th June at OXO2! Let’s connect in London — whether you're building something new in Longevity biotech, investing in the future, or just curious about where the field is going next. Register your interest here:

I’m excited to welcome Lord David Prior and Sir Tony Kouzarides to the team at Shift Bioscience! Joining as Chair of the Board, David brings a wealth of Board experience, including as Chairman of NHS England, to support the Company’s long term mission to comprehensively reverse

The dream of waking up in the near future and being substantially younger at a cellular level is something I have the rare privilege to pursue each day. However, keeping this dream alive is contingent on the following (1) making timely and meaningful technical progress towards

Rare moments make you stop, stare, and imagine their future impact. I’m thrilled to share one of those moments from our work at Shift Bioscience. Over the last few years, the data often felt unreal. Today we compare the single-gene SB000 (Shift Bioscience 000) with the

Single-gene rejuvenation target promises safer cell age reversal Shift Bioscience #longevitybiotech #aging longevity.technology/news/single-ge…

Genuine epigenetic rejuvenation in primary cells has long been the holy grail. A groundbreaking preprint reveals that over-expression of a single (secret) gene overcomes this barrier: greatly reduced age estimates across in fibroblasts and keratinocytes according to validated

The Sheekey Science Show breaks down the Shift Bioscience preprint 'A single factor for safer cellular rejuvenation' highlighting both the progress and caveats. Thanks Eleanor Sheekey for opening up the frontlines of cellular rejuvenation to a larger audience! youtube.com/watch?v=cH_Ige…

🆕 New LEVITY episode is live! Why tune in? Because a 24-person Cambridge startup may have beaten the billion-dollar OSK race with a single gene found by AI-powered virtual cells - and the early data look game-changing. (Links as always below.) Just about the hottest thing in

Thankyou Peter Ottsjö and Ingemar Patrick Linden for hosting me on the LEVITY LEVITY podcast to discuss our preprint 'A single factor for safer cellular rejuvenation' and beyond! youtube.com/watch?v=vdOVKZ…